Federal District Court Rochester
There will be a federal district court hearing July 20 in Rochester, N.Y., in two health centers' 340B-related antitrust suit against insulin and diabetes drug makers.

Health Centers’ Antitrust Case Over 340B Contract Pharmacy Limits Will be Argued July 20

A once-dead lawsuit that accuses drug makers of colluding to deny 340B pricing on insulin and diabetes drugs shipped to contract pharmacies is going to be heard July 20 in federal district court in Rochester, N.Y.

Chief Judge Elizabeth Wolford of U.S. District Court for the District of Western New York last week ordered that oral arguments be held on two community health centers’ motion to be allowed to file an amended antitrust complaint against AstraZeneca, Lilly, Novo Nordisk, and Sanofi.

A once-dead lawsuit that accuses drug makers of colluding to deny 340B pricing on insulin and diabetes drugs shipped to contract pharmacies is going to be heard July 20 in federal district court in Rochester, N.Y. Chief Judge Elizabeth Wolford […]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer